Fitch Ratings

Report: FDA Drug Approvals to Decline in 2012

Market research from Fitch Ratings indicates the FDA will approve fewer novel drugs in 2012 compared to 2011.

Fitch Ratings expects the Food and Drug Administration (FDA) will approve fewer novel drugs in 2012 as compared to 2011 while the industry faces several ongoing operational risks, according to a new report.

Your rating: None Average: 4 (5 votes)
Syndicate content